Cargando…

Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy

In March 2021, the coronavirus disease 2019 (COVID-19) pandemic still poses a threat to the global population, and is a public health challenge that needs to be overcome. Now more than ever, action is needed to tackle vaccine hesitancy, especially in light of the availability of effective and safe v...

Descripción completa

Detalles Bibliográficos
Autores principales: Reno, Chiara, Maietti, Elisa, Fantini, Maria Pia, Savoia, Elena, Manzoli, Lamberto, Montalti, Marco, Gori, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070202/
https://www.ncbi.nlm.nih.gov/pubmed/33924534
http://dx.doi.org/10.3390/vaccines9040378
_version_ 1783683415380328448
author Reno, Chiara
Maietti, Elisa
Fantini, Maria Pia
Savoia, Elena
Manzoli, Lamberto
Montalti, Marco
Gori, Davide
author_facet Reno, Chiara
Maietti, Elisa
Fantini, Maria Pia
Savoia, Elena
Manzoli, Lamberto
Montalti, Marco
Gori, Davide
author_sort Reno, Chiara
collection PubMed
description In March 2021, the coronavirus disease 2019 (COVID-19) pandemic still poses a threat to the global population, and is a public health challenge that needs to be overcome. Now more than ever, action is needed to tackle vaccine hesitancy, especially in light of the availability of effective and safe vaccines. A cross-sectional online survey was carried out on a representative random sample of 1011 citizens from the Emilia-Romagna region, in Italy, in January 2021. The questionnaire collected information on socio-demographics, comorbidities, past vaccination refusal, COVID-19-related experiences, risk perception of infection, and likelihood to accept COVID-19 vaccination. Multiple logistic regression analyses and classification tree analyses were performed to identify significant predictors of vaccine hesitancy and to distinguish groups with different levels of hesitancy. Overall, 31.1% of the sample reported hesitancy. Past vaccination refusal was the key discriminating variable followed by perceived risk of infection. Other significant predictors of hesitancy were: ages between 35 and 54 years, female gender, low educational level, low income, and absence of comorbidities. The most common concerns about the COVID-19 vaccine involved safety (54%) and efficacy (27%). Studying the main determinants of vaccine hesitancy can help with targeting vaccination strategies, in order to gain widespread acceptance—a key path to ensure a rapid way out of the current pandemic emergency.
format Online
Article
Text
id pubmed-8070202
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80702022021-04-26 Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy Reno, Chiara Maietti, Elisa Fantini, Maria Pia Savoia, Elena Manzoli, Lamberto Montalti, Marco Gori, Davide Vaccines (Basel) Article In March 2021, the coronavirus disease 2019 (COVID-19) pandemic still poses a threat to the global population, and is a public health challenge that needs to be overcome. Now more than ever, action is needed to tackle vaccine hesitancy, especially in light of the availability of effective and safe vaccines. A cross-sectional online survey was carried out on a representative random sample of 1011 citizens from the Emilia-Romagna region, in Italy, in January 2021. The questionnaire collected information on socio-demographics, comorbidities, past vaccination refusal, COVID-19-related experiences, risk perception of infection, and likelihood to accept COVID-19 vaccination. Multiple logistic regression analyses and classification tree analyses were performed to identify significant predictors of vaccine hesitancy and to distinguish groups with different levels of hesitancy. Overall, 31.1% of the sample reported hesitancy. Past vaccination refusal was the key discriminating variable followed by perceived risk of infection. Other significant predictors of hesitancy were: ages between 35 and 54 years, female gender, low educational level, low income, and absence of comorbidities. The most common concerns about the COVID-19 vaccine involved safety (54%) and efficacy (27%). Studying the main determinants of vaccine hesitancy can help with targeting vaccination strategies, in order to gain widespread acceptance—a key path to ensure a rapid way out of the current pandemic emergency. MDPI 2021-04-13 /pmc/articles/PMC8070202/ /pubmed/33924534 http://dx.doi.org/10.3390/vaccines9040378 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reno, Chiara
Maietti, Elisa
Fantini, Maria Pia
Savoia, Elena
Manzoli, Lamberto
Montalti, Marco
Gori, Davide
Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title_full Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title_fullStr Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title_full_unstemmed Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title_short Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
title_sort enhancing covid-19 vaccines acceptance: results from a survey on vaccine hesitancy in northern italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070202/
https://www.ncbi.nlm.nih.gov/pubmed/33924534
http://dx.doi.org/10.3390/vaccines9040378
work_keys_str_mv AT renochiara enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT maiettielisa enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT fantinimariapia enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT savoiaelena enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT manzolilamberto enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT montaltimarco enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly
AT goridavide enhancingcovid19vaccinesacceptanceresultsfromasurveyonvaccinehesitancyinnorthernitaly